Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

June 01, 1991; Volume 39,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Arvidsson, L E

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

B

  1. Baba, M

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  2. Baird, J G

    1. You have access
      Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
      J G Baird, R A Challiss and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 745-753;
  3. Balzarini, J

    1. You have access
      Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
      M Cools, J Balzarini and E De Clercq
      Molecular Pharmacology June 1991, 39 (6) 718-724;

C

  1. Catt, K J

    1. You have access
      Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;
  2. Challiss, R A

    1. You have access
      Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
      J G Baird, R A Challiss and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 745-753;
  3. Chatterjee, T K

    1. You have access
      Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
      T K Chatterjee and R A Fisher
      Molecular Pharmacology June 1991, 39 (6) 798-804;
  4. Clark, R B

    1. You have access
      Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
      M A Proll and R B Clark
      Molecular Pharmacology June 1991, 39 (6) 740-744;
  5. Cooke, A M

    1. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;
  6. Cools, M

    1. You have access
      Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
      M Cools, J Balzarini and E De Clercq
      Molecular Pharmacology June 1991, 39 (6) 718-724;
  7. Cornfield, L J

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;
  8. Costa, E

    1. You have access
      Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;
  9. Cox, B A

    1. You have access
      Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;

D

  1. De Clercq, E

    1. You have access
      Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
      M Cools, J Balzarini and E De Clercq
      Molecular Pharmacology June 1991, 39 (6) 718-724;
    2. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
    3. You have access
      Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

F

  1. Fisher, R A

    1. You have access
      Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
      T K Chatterjee and R A Fisher
      Molecular Pharmacology June 1991, 39 (6) 798-804;

G

  1. Gunji, H

    1. You have access
      Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

H

  1. Hacksell, U

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;
  2. Hammond, J R

    1. You have access
      Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
      J R Hammond
      Molecular Pharmacology June 1991, 39 (6) 771-779;
  3. Henningsen, R A

    1. You have access
      Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;
  4. Hwang, S B

    1. You have access
      Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
      S B Hwang and S Wang
      Molecular Pharmacology June 1991, 39 (6) 788-797;

I

  1. Iida, T

    1. You have access
      Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;

J

  1. Jansen, R W

    1. You have access
      Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;

K

  1. Kato, R

    1. You have access
      Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;
  2. Kharbanda, S

    1. You have access
      Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;
  3. Kufe, D

    1. You have access
      Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

L

  1. Lambert, G

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;

M

  1. Maksay, G

    1. You have access
      Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
      G Maksay, Z Tegyey and M Simonyi
      Molecular Pharmacology June 1991, 39 (6) 725-732;
  2. McBain, J

    1. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;
  3. Meijer, D K

    1. You have access
      Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;
  4. Mellin, C

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;
  5. Merelli, F

    1. You have access
      Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;
  6. Molema, G

    1. You have access
      Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;
  7. Mori, S

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  8. Murayama, N

    1. You have access
      Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;

N

  1. Nahorski, S R

    1. You have access
      Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
      J G Baird, R A Challiss and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 745-753;
    2. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;
  2. Nelson, D L

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;
  3. Neve, K A

    1. You have access
      Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;
  4. Neve, R L

    1. You have access
      Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;
  5. Nitta, I

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

O

  1. O'Donnell, J K

    1. You have access
      Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
      J K O'Donnell, R W Sweet and J M Stadel
      Molecular Pharmacology June 1991, 39 (6) 702-710;

P

  1. Pauwels, R

    1. You have access
      Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;
  2. Potter, B V

    1. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;
  3. Proll, M A

    1. You have access
      Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
      M A Proll and R B Clark
      Molecular Pharmacology June 1991, 39 (6) 740-744;
  4. Puia, G

    1. You have access
      Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;

R

  1. Rubin, E

    1. You have access
      Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
      E Rubin, S Kharbanda, H Gunji and D Kufe
      Molecular Pharmacology June 1991, 39 (6) 697-701;

S

  1. Safrany, S T

    1. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;
  2. Scammell, J G

    1. You have access
      Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;
  3. Schols, D

    1. You have access
      Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
      R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
      Molecular Pharmacology June 1991, 39 (6) 818-823;
  4. Seeburg, P H

    1. You have access
      Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;
  5. Sekiya, K

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  6. Shimada, M

    1. You have access
      Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;
  7. Simonyi, M

    1. You have access
      Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
      G Maksay, Z Tegyey and M Simonyi
      Molecular Pharmacology June 1991, 39 (6) 725-732;
  8. Spanoyannis, A

    1. You have access
      Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
      K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
      Molecular Pharmacology June 1991, 39 (6) 733-739;
  9. Stadel, J M

    1. You have access
      Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
      J K O'Donnell, R W Sweet and J M Stadel
      Molecular Pharmacology June 1991, 39 (6) 702-710;
  10. Stojilković, S S

    1. You have access
      Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
      S S Stojilković, T Iida, F Merelli and K J Catt
      Molecular Pharmacology June 1991, 39 (6) 762-770;
  11. Strada, S J

    1. You have access
      Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;
  12. Strupish, J

    1. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;
  13. Sweet, R W

    1. You have access
      Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
      J K O'Donnell, R W Sweet and J M Stadel
      Molecular Pharmacology June 1991, 39 (6) 702-710;

T

  1. Takashima, H

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  2. Tanaka, H

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  3. Tegyey, Z

    1. You have access
      Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
      G Maksay, Z Tegyey and M Simonyi
      Molecular Pharmacology June 1991, 39 (6) 725-732;
  4. Thompson, W J

    1. You have access
      Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;

U

  1. Ubasawa, M

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  2. Umezu, K

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;

V

  1. Vallgårda, J

    1. You have access
      Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
      L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
      Molecular Pharmacology June 1991, 39 (6) 780-787;
  2. Vicini, S

    1. You have access
      Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
      G Puia, S Vicini, P H Seeburg and E Costa
      Molecular Pharmacology June 1991, 39 (6) 691-696;

W

  1. Walker, R T

    1. You have access
      Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
      M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
      Molecular Pharmacology June 1991, 39 (6) 805-810;
  2. Wang, S

    1. You have access
      Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
      S B Hwang and S Wang
      Molecular Pharmacology June 1991, 39 (6) 788-797;
  3. Whalin, M E

    1. You have access
      Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
      M E Whalin, J G Scammell, S J Strada and W J Thompson
      Molecular Pharmacology June 1991, 39 (6) 711-717;
  4. Wojcikiewicz, R J

    1. You have access
      Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
      S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
      Molecular Pharmacology June 1991, 39 (6) 754-761;

Y

  1. Yamazoe, Y

    1. You have access
      Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
      N Murayama, M Shimada, Y Yamazoe and R Kato
      Molecular Pharmacology June 1991, 39 (6) 811-817;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 39, Issue 6
1 Jun 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics